The anticancerous drug isolated in our laboratory from estuarine Aeromonas was characterised and is found to be an enzyme, L-asparaginase. The antileukaemic effect of this drug was studied in mice by inducing leukaemia with Ehrlich ascites cell lines. It was compared with commercially available drug, Leunase, isolated from E. coil The lipid profiles in mice during leukaemia and under treatment was studied. The decreased levels of cholesterol and increased levels of triglycerides and phospholipids in serum, liver and kidney were observed in tumour bearing mice. Significant changes in the above values were observed with enzyme therapy. It could bring some of the values to near normal level. L-asparaginase from Aeromonas was found to be more effective.
INTRODUCTION
The enzyme, L-asparaginase isolated from E. coil and commercially available under the trade name 'Leunase' is used very significantly in the treatment of acute leukaemia. This enzyme catalyses the hydrolysis of L-asparagine which can not be synthesized by the sensitive tumour cells due to the deficiency of the enzyme asparagine synthetase. Normal cells, however, are able to synthesize L-asparagine from aspartic acid and ammonia with the help of asparagine synthetase and hence do not appear to have an absolute requirement for exogenous L-asparagine.
Reports available indicate that L-asparaginase isolated from different sources have different antineoplastic effect with varying immunological complications (1,2). L-asparaginase from estuarine Aeromonas isolated in our laboratory (3) was purified and the antileukaemic effect was studied (4). E. coil asparaginase contains two forms EC1 and EC2, of which EC2 is found to be antileukaemic. The advantage of the new drug over the commercially available drug is that the total enzyme is antileukaemic. Lipid profiles in cancer and under treatment were studied by several workers (5,6). Metabolism of carbohydrates, proteins and glycoproteins have also been studied extensively in cancer (7, 8) . But very little work is available in the metabolism of carbohydrates and glycoproteins during enzyme therapy (9, 10) . Similarly a few reports are available on the metabolism of lipids during L-asparaginase therapy (11, 12) .
Lipid profiles viz. cholesterol, tdglyceddes, and phospholipids in serum and tissues (liver and kidney) were studied in tumour bearing mice and under treatment with the drug isolated from Aeromonas and has been compared with Leunase and the results are discussed in this paper.
MATERIALS AND METHODS

Experimental Animals
Inbred Balb/c mice of 7 weeks age, weighing 14-17 g were used for the study. The mice were obtained from the stock inbred colony which was maintained by mating of brothers and sisters. The mice were maintained on dry pellets of laboratory feed (Gold Mohur rat feed, Hindustan Lever Ltd.) and tap water.
Tumour cell lines and their maintenance
Ehrlich ascites tumour cell line, kindly provided by Amala Cancer Research Institute, Trissur was used for the study. The tumour cell line was maintained by serial intraperitoneal (IP) transplantation in mice. Full grown tumour cells were aspirated from the mouse peritoneum, washed thrice with 0.9% saline, and suspended in saline. About 1 x 105 cells were injected intraperitoneally into a new healthy mouse. All operations were done aseptically. Solid tumour growth was obtained from the ascites cells by injecting 5 x 104 cells subcutaneously under an area of shaved skin on the flank.
Asparaginase Preparation
(a) Aeromonas L-asparaginase
Growing of cells, preparation of crude cell free extract and purification were done as described by Benny (4) . The enzyme preparation obtained after Ammonium sulfate precipitation, Gel permeation hydroxyapatite chromatography and lyophilization was dissolved in 0.9% saline.
(b) Leunase enzyme
The commercially available E. coil L-asparaginase, manufactured by Kyowa Hakko Kogyo Co. Ltd., Japan, marketed by Biochem India Ltd. under the trade name Leunase was used to compare the effect of Aeromonas L-asparaginase. The lyophilized enzyme preparation was also dissolved in 0.9% saline.
Experimental groups
Mice were divided into 7 groups, consisting of 6 mice in each group and were maintained as follows:
Group 1: Normal mice maintained with normal laboratory feed.
Group 2: Control group. Ehdich ascites tumour implanted mice. About 1 x 105 tumour cells were injected into the peritoneal cavity. These mice were not treated and were sacrificed on the 8th day of tumour implantation.
Group 3: Tumour implanted mice treated with Leunase. 24 h after tumour implantation, Leunase was administered thropgh the same route in 3 intermittent doses of 25 units, at an interval of 48h and were sacrificed on the 8th day of turnout implantation.
Group 4: Tumour implanted mice, treated with Aeromonas L-asparaginase. Injections were done as described earlier, and sacrificed on the 8th day of turnout implantation.
Group 5: Control mice bearing tumour, that were not treated. Sacrificed on the 15th day of turnout implantation.
Group 6: Tumour implanted mice treated with Leunase as in Group 3. Sacrificed on the 15th day of tumour implantation.
Group 7: Tumour implanted mice, treated with Aeromonas L-asparaginase preparation as in Group 4. Sacrificed on the 15th day of tumour implantation.
Blood from mice was collected, after the stipulated time by cutting the jtJgular vein with a sharp blade. Blood was allowed to clot and the serum was collected by centrifpgation at 1,500 rpm for 10 min. The liver and kidney were removed to ice cold containers, after washing with saline to remove the blood. 500 mg each of kidney and liver were homogenated with 5 ml distilled water in a Remi homogenizer to get a 10% homogenate. This homogenate and serum were used for the estimation of lipids. Extraction of the tissues for the estimation of cholesterol was carded out by the method of Abell et al. (13) . The triglycerides and phospholipids were estimated by the methods of Van and Zilversmit, and Zilversmit and Davis as described by Kurup et al. (14, 15) .
RESULTS AND DISCUSSION
Levels of Cholesterol, Triglycerides, phospho-9 lipids in serum and tissues (liver and kidney) of tumour bearing and L-asparaginase treated mice were studied and compared with those of normal. The results are given in Tables 1-3 . Biochemistry, 1997, 12 (2), 108-113 t09 Cholesterol levels in serum, liver and kidney were found to be decreased significantly with the progression of tumour growth. Highly elevated cholesterol level was observed in liver during administration of L-asparaginase, but the increase in serum and kidney were not found to be very significant. The increase in serum was pronounced in groups treated with Aeromonas L-asparaginase and at a later stage L-asparaginase administration resulted in concomitant increase of liver cholesterol.
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A significant elevation of tdglyceride levels in serum and liver was found during the early stages of tumour growth and no change was observed in kidney. Highly elevated levels of triglycerides in liver was found during the later stages of tumour growth but the change in kidney was not very significant. Triglyceride levels in liver and kidney were found to be increased with administration of L-asparaginase. But increase was more significant in kidney. A few days after the cessation of therapy, a significant reduction in tdglyceride level in serum was observed. In groups treated with Aeromonas L-asparaginase, serum triglyceride values returned to near normal Serum phospholipids increased significantly during the eady stage of turnout growth. In kidney, lndtan Journal of Climcal Biochemistry, 1997, 12 (2), 108-113 its level was found to be decreased. The serum phospholipids remain elevated and the liver phospholipids returned to normal at a later stage of tumour growth. Kidney phospholipids were found to be decreased during the early stage oftumour growth and increased during the later stage. In serum, its level was found to be elevated after L-asparaginase administration. Cessation of therapy resulted in significant decrease in groups treated with Aeromonas L-asparaginase and no significant decrease was observed in groupstreated with Leunase. Phospholipids in liver was also altered significantly upon the administration of both E. coli and Aeromonas L-asparaginase. In kidney, its level was found to be decreased immediately after Lasparaginase administration, but a few days after the cessation of therapy, the level decreased significantly. This decrease was more marked in groups treated with E. coil L-asparaginase.
The lipid profile in patients with malignancies was studied by Kritchevsky et al. and reported that cholesterol level in patients with non localized malignancies dropped belowthe normal level (5). These alterations might be useful as differential markers with the more mature leukaemia having more complex glycotipids as spggested by William et al. (6) . He found that the composition of neutral tll glycosphingolipids in acute leukaemic cells differs significantly from that found in normal or chronic leukaemic cells. Only a few reports are available on the effect of L-asparaginase on lipid metabolism. Low serum cholesterol has been reported and has been shown to be related to decrease in the serum alpha, pre-I~ and I:~ lipoproteins (10,11). Hypocholesterolemia associated with Lasparaginase therapy may be due to decreased synthesis of proteins required for the transport of cholesterol (12) . Reports available spggests that there is no clear relationship between tumour growth and triglyceride pattern. However, in the present study we observed a significant elevation of serum triglyceride levels. The increased triglyceride levels observed in serum and liver during tumour growth might be due to the decreased production of enzymes concerned with the catabolism of triglycerides or may be due to increased biosynthesis, since lipoprotein lipase, triglyceride lipase and other enzymes of triglyceride/lipoprotein metabolism could not be studied, a definite conclusion could not be drawn. At a later stage of therapy, the triglyceride levels in serum decreased and cameto near normal level in Aeromonas L-asparaginase treated groups. A decreased level in serum during therapy was an important observation.
Hypocholesterolemia associated with L-asparaginase therapy has been related to the decreased synthesis of proteins necessary for cholesterol transport (10, 12) . Hypocholesterolemia observed in both L-asparaginase treated and nontreated tumour bearing mice in the present study is in agreement with the views suggested by Kritchevsky et al. (5) . Decreased cholesterol level may be due to the growth of tumour rather than the direct action of L-asparaginase. Haskal et al. and Yoon et al. have suggested that L-asparaginase administration cause fat infiltration into hepato parenchymal cells of man and mice (11, 12) . An increase in phospholipids in fatty liver was observed by Yoon et al. (12) . They also observed fat infiltration and numerous irregular size lipid droplets in the paranchymal cells of mice treated with L-asparaginase. Histolog;. ~ examination of the liver showed fat infiltration in man during the first two weeks of treatment which subsides upon cessation of L-asparaginase therapy (10,11). The elevated levels of phospholipids and triglycerides in liver and kidney in the present study might be due to fat infiltration.
